3653 results for «358»

Filter By

3653 results

Uncommon complications in NSTEMI

22 Sep 2023 – From AICT-AsiaPCR 2023

Discoversome unforeseen challenges in NSTEMI cases in this session, ranging from managing coronary air embolisms and distinguishing between inflammation and infarction to dealing with coronary aneurysms at the left main coronary artery bifurcation and addressing type 5 coronary perforation. 

Uncommon complications in NSTEMI

Advanced techniques for managing calcified lesions

22 Sep 2023 – From AICT-AsiaPCR 2023

Discover advanced strategies for tackling complex calcified lesions in this session: from innovative approaches like the 'Orbital-shock' technique to managing calcified lesions in patients with previous CABG and in-stent restenosis, and exploring calcium modification strategies tailored to specific cases, these presentations offer valuable insights into simplifying...

Advanced techniques for managing calcified lesions

Complex CTO challenges

22 Sep 2023 – From AICT-AsiaPCR 2023

Gain valuable insights into overcoming CTO challenges in this session: learn how IVUS can come to the rescue in cases of main branch cut-off, discover successful recanalization techniques for right coronary artery CTOs using very long epicardial channels and explore the best approaches for managing complex...

Complex CTO challenges

Learning - Cardiogenic shock

22 Sep 2023 – From AICT-AsiaPCR 2023

Explore the complexities of cardiogenic shock management in this session: understand its pathophysiology, learn about the role of mechanical support (IABP, Impella, ECMO) in addition to pharmacological treatment, gather tips and tricks from expert speakers and gain insights into real-world cases.

Learning - Cardiogenic shock

Other valvular interventions

22 Sep 2023 – From AICT-AsiaPCR 2023

Explore innovative approaches to various valvular interventions in this session: from managing post-mitral valve replacement complications and performing balloon mitral valvotomy in patients with restenosis after mitral valve interventions to tackling calcified mitral valves and addressing unique cases like LBB pacing in isolated ccTGA with complete...

Other valvular interventions

Advanced approaches to treating calcified lesions

22 Sep 2023 – From AICT-AsiaPCR 2023

Discover advanced insights into calcified lesions in this session, covering topics such as: managing double disasters, treating severe calcified left main disease, addressing complications in double vessel rotablation with left main bifurcation stenting, and using rotatripsy in OCT-guided PCI for calcified left anterior descending artery.

Advanced approaches to treating calcified lesions

How to manage complications in CTO PCI

22 Sep 2023 – From AICT-AsiaPCR 2023

Explore complex CTO PCI scenarios and gain insights into complications and their solutions in this session. Topics include CTO vessel rupture after a covered stent bailout, epicardial channel perforation management, dissection from collateral tip injection, and more!

How to manage complications in CTO PCI

Spontaneous coronary artery disease, INOCA, MINOCA in women

21 Sep 2023 – From AICT-AsiaPCR 2023

Consult this session to better understand the causes of myocardial infarction without obstructive disease (MINOCA), to revisit ischemia with no obstructive coronary atherosclerosis (INOCA), and to broaden your understanding of spontaneous coronary artery dissection (SCAD) beyond its association with pregnancy.

Spontaneous coronary artery disease, INOCA, MINOCA in women

SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk

07 Nov 2021

Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...

Paola Redaelli

Author

Paola Redaelli
M. Pighi

Author

Michele Pighi
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk

World Heart Day 2023: Reducing the burden of cardiovascular disease globally: beyond stents and balloons!

29 Sep 2023

Global burden of Cardiovascular Disease

Cardiovascular disease (CVD) remains the lead cause of mortality for men and women globally. Our world population in 2023 is 8 billion! Of these, around 620 million people are living with heart and circulatory diseases across the world. Each year around 60...

Vijay Kunadian

Author

Vijay Kunadian
World Heart Day 2023

The Lancet Commission to reduce global burden of cardiovascular disease in women by 2030

29 Aug 2021

Vijay Kunadian summarizes the key points of the LBT session of the ESC congress 2021 held on Sunday, 29 August focusing on the Lancet Commission to reduce the global burden of heart disease in women by 2030.

Vijay Kunadian

Author

Vijay Kunadian
ESC Congress 2021 - Global burden of cardiovascular disease in women; 20/20 vision for 2030: report of The Lancet commission

BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

07 Nov 2022

Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.

This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...

Nicola Ryan

Author

Nicola Ryan
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions

08 Jan 2025

In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.

Author

Bruno Scheller
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
Didn’t find what you were looking for?